You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

The Next Frontier in Treatment of Atopic Dermatitis in Children

Presentations from the ADVENT symposium at the EAACI 2022 congress on treating atopic dermatitis in children.

Antonella Muraro
Andreas Wollenberg
Antonella Muraro +1 more

Learning objectives

  • Explore the impact of AD on children and their families/caregivers
  • Describe the approval and investigational status of therapeutic agents for the management of AD patients <12 years
  • Review available clinical trial safety and efficacy in children with AD <12 years (dupilumab)


In this ADVENT symposium at the 2022 EAACI congress, “The Next Frontier in Treatment of Atopic Dermatitis in Children”, Antonella Muraro, MD, PhD (Padua General University Hospital), and Andreas Wollenberg, MD, PhD (University of Munich), reviewed the impact of atopic dermatitis (AD) on pediatric patients and their caregivers, and the targeted therapeutic options for children with AD.

MAT-GLB-2202962 V2 07/2022

About these experts

Related resources